Atlas Trials

An Observational Study on Long-Term Effectiveness and Safety of RoActemra/Actemra (Tocilizumab) in Daily Practice in Patients With Rheumatoid Arthritis (ICHIBAN)

Clinical trial NCT01194401 · UNKNOWN

Trial details

NCT number
NCT01194401
Sponsor
Hoffmann-La Roche
Status
UNKNOWN
Study type
OBSERVATIONAL
Rheumatoid Arthritis
Enrollment
3404

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.